1. Introduction {#s0005}
===============

There has been a decline in transition rates into psychosis in cohorts of individuals at high risk (HR) of developing psychosis across different centres worldwide, over the last few years ([@bb0205]). Different psychological and pharmacological interventions have not significantly reduced transitions in recent randomised controlled trials ([@bb0140; @bb0145]). This may suggest that the focus of research in this population group needs updating.

Growing evidence is indicating that psychosis may lie on a continuum, with mild psychotic symptoms or psychotic-like experiences at one end and schizophrenia and related psychotic disorders at the other ([@bb0120; @bb0180; @bb0040; @bb0090; @bb0185]). Recent studies including population-based samples also suggest that nearly 80% of the adolescents who report psychotic-like symptoms may have at least one other psychiatric disorder ([@bb0105; @bb0115]). Furthermore, co-presence of psychotic symptoms in adolescents and young adults with disorders of anxiety and depression appears to be more prevalent than previously considered, and an etiological and functionally relevant feature ([@bb0210]).

Psychotic experiences may also act as markers for non-psychotic psychiatric disorders in individuals at clinical HR for psychosis. [@bb0065] found that 73% of the HR individuals recruited to their study (n = 509) had at least one Axis I comorbid diagnosis, with major depression as predominant diagnosis, followed by anxiety disorders. Similarly, [@bb0170] identified comorbid psychiatric disorders in almost 80% of their HR sample (n = 245).

It is therefore important to thoroughly understand the type and severity of psychopathology in people at HR for psychosis in order to develop specific care pathways and interventions that this group could likely benefit from. To achieve this goal, comparisons with healthy volunteers to evaluate the overall psychiatric morbidity and subsequent impact on quality of life and functioning in HR individuals are highly recommended. It is noteworthy that these comparisons are still very limited in the current scientific literature, with only a handful of studies assessing the real impact of HR mental states on functioning and quality of life ([@bb0190; @bb0070; @bb0065]).

The aims of this study were to further delineate the clinical manifestations of young people at HR for psychosis at the time of their referral to mental health services and evaluate their level of global functioning, occupational status and quality of life in comparison to a sample of healthy volunteers recruited from the same geographical area.

2. Methods {#s0010}
==========

We compared demographic, psychiatric morbidity, functioning and quality of life measures between help-seeking HR individuals and healthy volunteers recruited from Cambridgeshire, UK.

2.1. Setting {#s0015}
------------

CAMEO (<http://www.cameo.nhs.uk>) is an early intervention service in psychosis which offers management for people aged 14--35 years suffering from first-episode psychosis (FEP) in Cambridgeshire, UK. CAMEO also accepts referrals of people at HR aged 16--35. Referrals are accepted from multiple sources including general practitioners, other mental health services, school and college counsellors, relatives and self-referrals ([@bb0030]).

2.2. Sample {#s0020}
-----------

A consecutive cohort of 60 help-seeking individuals, aged 16--35, referred to CAMEO Early Intervention in Psychosis Service from February 2010 to September 2012 met criteria for HR, according to the Comprehensive Assessment of At Risk Mental States (CAARMS) ([@bb0200]). From this assessment, HR individuals were divided into three groups based on whether they were mainly characterised by: i) vulnerability traits (family history of psychosis in first degree relative plus significant drop in functioning levels within past 12 months), ii) attenuated psychotic symptoms, or iii) brief limited intermittent psychotic symptoms (BLIPS). In our sample, all individuals fulfilled criteria for the attenuated psychotic symptoms\' group. Seven individuals (11.7%) also qualified for the vulnerability traits\' group. Intake exclusion criteria included: i) acute intoxication or withdrawal associated with drug or alcohol abuse or any delirium, ii) confirmed intellectual disability (Wechsler Adult Intelligence Scale --- tested IQ \< 70), or iii) prior total treatment with antipsychotics for more than one week.

During the same period (February 2010--September 2012), a random sample of 45 healthy volunteers was recruited by post, using the Postcode Address File (PAF®) provided by Royal Mail, UK. Healthy volunteers interested in the study could only participate if they were aged 16--35, resided in the same geographical area as HR participants (Cambridgeshire), and did not have previous contact with mental health services. They were recruited for the exclusive purpose of this research.

2.3. Ethical approval {#s0025}
---------------------

Ethical approval was granted by the Cambridgeshire East Research Ethics Committee.

2.4. Measures {#s0030}
-------------

All participants were assessed with sociodemographic (age, gender, ethnicity, education level, marital status, and living accommodation), psychiatric morbidity, functioning and quality of life measures at the time of their referral to CAMEO. The assessments were carried out by senior research clinicians trained in each of the measurement tools. HR participants were also interviewed by senior trained psychiatrists working in CAMEO, using the Mini International Neuropsychiatric Interview (MINI), Version 6.0.0, a brief structured diagnostic interview for DSM-IV Axis I psychiatric disorders ([@bb0175]).

The Positive and Negative Syndrome Scale (PANSS) for psychotic symptoms was employed to capture the severity of positive symptoms (7 items), negative symptoms (7 items) and general psychopathology (16 items) in a 7-point scale, with higher scores indicating greater severity of illness ([@bb0100]). Summary score and sub-domain scores of positive, negative and general psychopathology symptoms were computed.

The Beck Depression Inventory Version II (BDI-II) ([@bb0025]) and the Beck Anxiety Inventory (BAI) ([@bb0015]) were used to assess depressive and anxiety symptoms respectively. The BDI-II is a widely used self-complete instrument to assess depressive symptom severity in the past two weeks. It consists of 21 items rated on a 4-point scale from absent (0), mild (1), moderate (2) to severe (3). In addition to item scores, a composite score (range 0--63 points) was calculated by summing individual items in the BDI-II. The composite score was used to further divide participants into 4 groups in which scores of 0--13 indicates minimally depressed, 14--19 mildly depressed, 20--28 moderately depressed and 29--63 severely depressed ([@bb0045]). For the purpose of this study, the BDI-II item 9 on current suicidal thoughts or wishes was used to categorize subjects into absent (scoring 0) or present (scoring 1--3) suicidal ideation. Likewise, the BAI is a 21-item self-complete measure of anxiety symptoms also rated on a 4-point scale, from 0 indicating absent to 3 indicating severe. Individual item scores and composite score (range 0--63) were computed. Participants were further divided into 4 groups according to their BAI composite score: scores of 0--7 indicates minimal anxiety, 8--14 mild anxiety, 16--25 moderate anxiety, and 26--63 severe anxiety ([@bb0020]).

Manic symptoms were assessed using the Young Mania Rating Scale (YMRS) ([@bb0195]). The scale has 11 items --- while 7 items on elevated mood, increased motor activity--energy, sexual interest, sleep, language--thought disorder, appearance and insight were rated from 0 (absence) to 4 (severe), the remaining 4 items on irritability, speech, content and disruptive--aggressive behaviour were rated from 0 (absent) to 8 (severe). A summary score of all the items of the YMRS was calculated (range 0--60).

The Yale--Brown Obsessive Compulsive Symptom Checklist and Severity Scales (YBOCS) ([@bb0050]) were used to examine the presence and severity of obsessions and compulsions. The proportion of subjects having obsessions and/or compulsions in each group was calculated. For those who had at least one obsession and/or compulsion, the mean total severity scores were also generated.

The Global Assessment of Functioning (GAF) is a commonly used functioning scale in psychiatric research ([@bb0075]). The GAF assesses global functioning in the past month. Both symptoms and disability dimensions were assessed using an impression score of 1 to 100, with 10 points separating each level ([@bb0060]), and lower scores representing higher severity of symptoms and poorer level of functioning respectively. Occupational status was also recorded.

Quality of life was assessed using the Manchester Short Assessment of Quality of Life (MANSA) ([@bb0165]). The subjective and objective dimensions of quality of life were captured. For the purpose of this study, the subjective dimension comprising of the following domains was analysed: life in general, health, work and education, finance, leisure, safety, living situation, social and family relations. Each item is rated from 1 (worst) to 7 (best possible satisfaction). The overall mean subjective quality of life score was computed by averaging all the items in the subjective dimension ([@bb0055]).

2.5. Statistical analysis {#s0035}
-------------------------

All analyses were performed using version 20 of SPSS (SPSS, Inc., Chicago, Illinois). We compared sociodemographic information between HR individuals and healthy volunteers. Clinical morbidity measures including PANSS, BDI-II, BAI, YMRS and YBOCS, functioning measures including GAF and occupational status, as well as subjective quality of life measured by MANSA were further compared between the two groups. All comparisons were made using chi-square test or Fisher\'s exact test for categorical variables and *t*-test or Mann--Whitney *U* test for continuous variables. A p-value of less than 0.05 represents a significant difference.

3. Results {#s0040}
==========

3.1. Sociodemographic profile {#s0045}
-----------------------------

The whole study population had a mean age of 20.7 years (SD = 3.4). Gender was nearly evenly split between male (n = 55; 52.4%) and female (n = 50; 47.6%). [Table 1](#t0005){ref-type="table"} compares the basic demographics between HR individuals and healthy volunteers. Both groups did not differ in age, gender, ethnicity and current accommodation type. Less HR individuals achieved higher education degrees (p = 0.001) compared to healthy volunteers, and more HR individuals were single (p = 0.033). A significant proportion of HR individuals were on antidepressant or/and anxiolytic medication (41.7%) at the time of their first contact with CAMEO.

3.2. Psychiatric morbidity {#s0050}
--------------------------

We obtained MINI DSM-IV diagnoses for 55 of the 60 HR individuals. 38 (69.1%) had more than one DSM-IV psychiatric diagnosis, mainly within the affective and anxiety diagnostic spectra. Primary diagnoses for this group were ranked as follows: major depressive episode, current or recurrent (n = 26; 47.3%) \> social phobia (n = 7; 12.7%) = generalised anxiety disorder (n = 7; 12.7%) \> obsessive compulsive disorder (n = 5; 9.1%) \> bipolar disorder, type II (n = 2; 3.6%) \> panic disorder (n = 1; 1.8%) = posttraumatic stress disorder (n = 1; 1.8%). Six HR individuals (10.9%) did not fulfil enough criteria for a DSM-IV Axis I diagnosis.

[Table 2](#t0010){ref-type="table"} shows that HR individuals had higher scores (i.e., greater symptom severity) in total PANSS and all its sub-domains, including positive, negative and general psychopathology symptoms compared with healthy volunteers (all with p \< 0.001). However, all scores suggested a "mildly ill" group with regard to psychotic symptoms ([@bb0135]).

HR individuals also had a higher total BDI-II score (i.e., more depressed) than controls (29.9 ± 12.8 vs. 5.6 ± 5.5, p \< 0.001). This difference was significant in all items. We further divided participants into 4 groups according to their total scores in BDI-II. HR individuals were significantly more likely to be severely or moderately depressed (54.0% vs. 0%, p \< 0.001 and 20.0% vs. 4.5%, p = 0.025, respectively). We tested if HR individuals who were currently on antidepressants (n = 24) had a higher baseline BDI-II score than those who were not on antidepressants (n = 36). However, no difference on the means of BDI-II sum scores was observed between the two groups (32.7 ± 12.4 vs. 27.8 ± 13.0, p = 0.184). HR individuals had a 72.0% endorsement in suicidal thoughts or intention, as measured with item 9 of BDI-II, whereas only 9.1% of healthy volunteers had positive response in this item (p \< 0.001).

Similarly, BAI scores showed that HR individuals had more anxiety symptoms (28.2 ± 11.9 vs. 6.7 ± 5.6, p \< 0.001). Indeed, 41 HR individuals (85.4%) suffered moderate or severe anxiety symptoms.

Although HR individuals had a significant higher YMRS score than healthy volunteers (p \< 0.001), the mean score was 3.9 (SD = 4.1), suggesting subclinical severity.

Approximately 80% of HR individuals had experienced at least one obsessive symptom. Among those who had any obsession or compulsion, the mean of YBOCS total severity score was significantly higher in HR individuals than healthy volunteers (20.1 ± 5.8 vs. 5.3 ± 1.5, p \< 0.001), suggesting moderate and subclinical severity respectively.

3.3. Transitions from HR to FEP {#s0055}
-------------------------------

After more than one year of follow-up for each individual at HR in our sample, only 6 (10%) made a transition into FEP. We obtained MINI DSM-IV diagnoses at baseline for 5 of them. 4 had an initial diagnosis of major depression, current or recurrent, and one did not fulfil enough criteria for a DSM-IV mental disorder. None of the HR individuals from this cohort received antipsychotics during the follow-up period, but they were treated with other psychiatric medications, i.e. anxiolytics and/or antidepressants, if clinically required.

3.4. Functioning and quality of life {#s0060}
------------------------------------

[Table 3](#t0015){ref-type="table"} compares functioning, employment status, and quality of life between HR and healthy individuals. HR subjects had poorer functioning, with much lower scores in GAF symptoms and disability than healthy volunteers (45.4 ± 8.9 vs. 86.6 ± 3.8 and 48.6 ± 9.4 vs. 86.7 ± 3.6, respectively, both with p \< 0.001), suggesting that individuals with HR mental states suffered serious psychiatric symptoms and any serious impairment in social, occupational or academic functioning. Higher unemployment rate was found in the HR group (37.7% vs. 17.8%, p = 0.029). HR individuals also reported poorer quality of life (3.8 ± 1.0 vs. 5.6 ± 0.6, p \< 0.001).

4. Discussion {#s0065}
=============

This study compared psychiatric morbidity, functioning and quality of life between 60 young people at HR for psychosis at the time of their referral to CAMEO and 45 healthy volunteers. Overall, our findings indicate that, beyond psychotic symptoms, there are many other psychopathological conditions that may be interfering in the global functioning of those at HR. More specifically, our study showed that HR individuals i) suffered a wide range of psychiatric disorders and mild psychotic symptoms, ii) reported more suicidal ideation/intention, depressive and anxiety symptoms, and iii) presented with worse levels of functioning, quality of life and employment status than healthy volunteers.

These results are in line with previous evidence suggesting a significant association between HR mental states and several other psychiatric disorders ([@bb0065; @bb0170]). We found that almost 70% of HR individuals in our sample had more than one DSM-IV Axis I diagnosis. In particular, HR individuals had a statistically significant higher prevalence of moderate/severe depression, anxiety, obsessive--compulsive behaviours, and suicidality than healthy volunteers.

Our results suggest that individuals at HR are a heterogeneous group which tends to present with more than one psychiatric disorder, mainly depression and/or anxiety-related. Suicidal ideation and intention were also very prevalent in our HR cohort. Previous studies have reported similar enhanced risk of suicide in population-based and clinical samples ([@bb0160; @bb0080; @bb0105; @bb0115]). This could be related to a variety of factors, such as comorbid psychiatric disorders ([@bb0035]), distress associated with psychotic-like experiences or mild psychotic symptoms, especially auditory hallucinations ([@bb0130]), and mood variability ([@bb0155]).

Recent studies, both in adolescent and adult populations, have already shown a strong relationship between HR for psychosis and presence of comorbid mood and anxiety disorders ([@bb0105; @bb0115; @bb0210]). These associations might be even stronger at earlier stages of development, where psychotic experiences among young adolescents appear to follow a dose--response pattern in the prediction of a wide variety of future psychopathology ([@bb0105; @bb0115]). Interestingly, in contrast with previous findings that described a direct relationship between the degree of psychotic symptoms and comorbid psychiatric disorders in young people, individuals at clinical HR in our sample were affected by mild psychotic symptoms.

Our findings highlight the lack of specificity and predictive value of psychotic symptoms and carry important implications for clinicians and researchers in the field of psychosis. Psychotic experiences appear to be common, not only among those patients who suffer from a psychotic illness, but also from other disorders such as depression and anxiety ([@bb0210]). Although the causal mechanisms of this association are not well understood, it has been hypothesized that a HR mental state may be an indicative marker of risk for multiple psychiatric disorders ([@bb0105; @bb0115]). During childhood and adolescence, clinical phenotypes of different psychiatric disorders might overlap, reaching a greater differentiation throughout adulthood ([@bb0125; @bb0095]). Also, traumatic events in childhood could eventually manifest as psychotic-like symptoms in the context of non-psychotic psychiatric disorders ([@bb0110]). Therefore, psychotic and non-psychotic disorders may share similar risk factors and these could have an impact on neurodevelopmental processes that may involve genetic, structural and/or neurobiological changes, resulting in different psychiatric syndromes ([@bb0085; @bb0005; @bb0150]). It is also possible that mild psychotic symptoms experienced by HR individuals may contribute to the development of other psychiatric disorders.

Notably, people at HR in our and other samples ([@bb0010; @bb0065; @bb0215]) endorsed a remarkably poor global functioning and quality of life, which was particularly striking when we compared them to healthy volunteers from the same region. This would justify special attention from mental health services in order to develop appropriate care pathways for a population also characterised by a significant risk of suicidality, regardless of current uncertainties on the mechanisms underlying these presentations. On the basis of our findings, clinical interventions in individuals at HR indentified in early intervention in psychosis services should aim at targeting a broader range of psychopathology, especially mood and anxiety symptoms, rather than just focusing on the treatment and/or prevention of psychosis.

4.1. Limitations {#s0070}
----------------

One of the limitations of the study is its cross-sectional nature, where causal inferences on the HR state, psychiatric morbidity and impaired functioning cannot be made. Efforts to follow-up this HR cohort are being undertaken in order to assess if HR mental states are associated with the development of functional difficulties and psychiatric morbidity. Also, the study only included people aged 16--35 years, which might affect the generalisability of our results. However, this is a valuable homogenous cohort with all individuals mainly suffering from attenuated psychotic symptoms. Furthermore, we did not match the study groups on educational level, yet the groups did not differ with respect to age, gender and ethnicity. Finally, we did not include a chronicity criterion to determine whether people with longer duration of HR mental state criteria had a different profile of psychopathology from those with shorter duration.
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###### 

Sociodemographic comparison between HR individuals and healthy volunteers.

  Sociodemographic characteristics^†^             HR (n = 60)   HV (n = 45)   p-Value
  ----------------------------------------------- ------------- ------------- -------------------------------------------
  Age at study entry, years, mean (SD)            20.2 (2.9)    21.4 (3.9)    0.088[a](#tf0100){ref-type="table-fn"}
  Gender, male, n (%)                             31 (51.7)     24 (53.3)     0.866[b](#tf0105){ref-type="table-fn"}
  Ethnicity, n (%)^‡^                                                         
   White                                          56 (93.3)     41 (91.1)     0.722[c](#tf0110){ref-type="table-fn"}
   Mixed                                          2 (3.3)       3 (6.7)       0.649[c](#tf0110){ref-type="table-fn"}
   Asian                                          1 (1.7)       1 (2.2)       1.000[c](#tf0110){ref-type="table-fn"}
   Black                                          1 (1.7)       0 (0)         1.000[c](#tf0110){ref-type="table-fn"}
  Education level, n (%) (9)                                                  
   Primary                                        5 (9.8)       0 (0)         0.058[c](#tf0110){ref-type="table-fn"}
   Secondary                                      26 (51.0)     10 (22.7)     0.006[c](#tf0110){ref-type="table-fn"}
   Further^§^                                     17 (33.3)     20 (45.5)     0.298[c](#tf0110){ref-type="table-fn"}
   Higher                                         3 (5.9)       15 (31.8)     0.001[c](#tf0110){ref-type="table-fn"}
  Marital status, n (%) (7)                                                   
   Single                                         48 (90.6)     33 (73.3)     0.033[c](#tf0110){ref-type="table-fn"}
   Married/co-habiting                            5 (9.4)       11 (24.4)     0.057[c](#tf0110){ref-type="table-fn"}
   Divorced/dissolved                             0 (0)         1 (2.2)       0.459[c](#tf0110){ref-type="table-fn"}
  Current accommodation type, n (%) (6)                                       
   Detached house                                 13 (24.1)     15 (33.3)     0.372[c](#tf0110){ref-type="table-fn"}
   Semi-detached house                            18 (33.3)     10 (22.2)     0.266[c](#tf0110){ref-type="table-fn"}
   Terraced house                                 12 (22.2)     12 (26.7)     0.644[c](#tf0110){ref-type="table-fn"}
   Flat                                           4 (7.4)       7 (15.6)      0.219[c](#tf0110){ref-type="table-fn"}
   Bedsit/studio                                  1 (1.9)       0 (0)         1.000[c](#tf0110){ref-type="table-fn"}
   Communal establishment                         6 (11.1)      1 (2.2)       0.123[c](#tf0110){ref-type="table-fn"}
  Current psychiatric medication, n (%)           25 (41.7)     0 (0)         \< 0.00[b](#tf0105){ref-type="table-fn"}
  Current psychiatric medication type, n (%)^⁎^                               
   Antipsychotics                                 0 (0)         0 (0)         --
   Antidepressants                                24 (38.3)     0 (0)         \< 0.001[c](#tf0110){ref-type="table-fn"}
   Anxiolytics                                    2 (1.7)       0 (0)         0.505[c](#tf0110){ref-type="table-fn"}
   Both antidepressants and anxiolytics           1 (1.7)       0 (0)         1.000[c](#tf0110){ref-type="table-fn"}

HR = high risk; HV = healthy volunteers; SD = standard deviation; n = number.

^†^Number of missing observations in brackets.

^‡^'White ethnicity' refers to subjects who are White British, White Irish, or other White backgrounds. 'Mixed ethnicity' refers to those who are White and Black Caribbean, mixed White and Black African, mixed White and Asian, or any other mixed backgrounds. 'Asian ethnicity' refers to those who are Indian or Chinese. 'Black ethnicity' refers to subject from any Black backgrounds.

^§^UK National Vocational Qualifications (NVQs) or A-Levels.

^⁎^Multiple answers were allowed for those who had any psychiatric medication taken during study entry.

Independent *t*-test.

Chi-square test.

Fisher\'s exact test.

###### 

Clinical comparison between HR individuals and healthy volunteers.

  Clinical characteristics^†^        HR (n = 60)   HV (n = 45)   p-Value
  ---------------------------------- ------------- ------------- -------------------------------------------
  PANSS, mean (SD) (6)                                           
   Positive                          13.1 (3.2)    7.1 (0.5)     \< 0.001[a](#tf0005){ref-type="table-fn"}
   Negative                          12.4 (5.0)    7.8 (0.9)     \< 0.001[a](#tf0005){ref-type="table-fn"}
   General psychopathology           32.7 (7.0)    16.3 (1.3)    \< 0.001[a](#tf0005){ref-type="table-fn"}
   Sum of all items                  58.2 (12.1)   31.3 (1.9)    \< 0.001[a](#tf0005){ref-type="table-fn"}
  BDI-II (11)                                                    
   Sum of all items, mean (SD)       29.9 (12.8)   5.6 (5.5)     \< 0.001[a](#tf0005){ref-type="table-fn"}
   Suicidality (score 1--3), n (%)   36 (72.0)     4 (9.1)       \< 0.001[b](#tf0045){ref-type="table-fn"}
   Depression subgroup, n (%)                                    \< 0.001[b](#tf0045){ref-type="table-fn"}
   Minimal (score 0--13)             5 (10.0)      39 (88.6)     \< 0.001[b](#tf0045){ref-type="table-fn"}
   Mild (score 14--19)               8 (16.0)      3 (6.8)       0.167[b](#tf0045){ref-type="table-fn"}
   Moderate (score 20--28)           10 (20.0)     2 (4.5)       0.025[b](#tf0045){ref-type="table-fn"}
   Severe (score 29--63)             27 (54.0)     0 (0)         \< 0.001[b](#tf0045){ref-type="table-fn"}
  BAI (15)                                                       
   Sum of all items, mean (SD)       28.2 (11.9)   6.7 (5.6)     \< 0.001[a](#tf0005){ref-type="table-fn"}
   Anxiety subgroup, n (%)                                       \< 0.001[b](#tf0045){ref-type="table-fn"}
   Minimal (score 0--7)              2 (4.2)       29 (67.4)     \< 0.001[b](#tf0045){ref-type="table-fn"}
   Mild (score 8--15)                5 (10.4)      9 (20.9)      0.165[b](#tf0045){ref-type="table-fn"}
   Moderate (score 16--25)           12 (25.0)     5 (11.6)      0.102[b](#tf0045){ref-type="table-fn"}
   Severe (score 26--63)             29 (60.4)     0 (0)         \< 0.001[b](#tf0045){ref-type="table-fn"}
  YMRS (7)                                                       
   Sum of all items, mean (SD)       3.9 (4.1)     0.5 (1.2)     0.001[a](#tf0005){ref-type="table-fn"}
  YBOCS (13)                                                     
   Having obsession, n (%)           37 (77.1)     2 (4.5)       \< 0.001[b](#tf0045){ref-type="table-fn"}
   Having compulsion, n (%)          34 (70.8)     1 (2.3)       \< 0.001[b](#tf0045){ref-type="table-fn"}
   Sum of all items, mean (SD)       20.1 (5.8)    5.3 (1.5)     \< 0.001[a](#tf0005){ref-type="table-fn"}
   Severity subgroups, n (%)                                     \< 0.001[b](#tf0045){ref-type="table-fn"}
   Subclinical (score 0--7)          2 (5.4)       3 (100)       0.001[c](#tf0050){ref-type="table-fn"}
   Mild (score 8--15)                5 (13.5)      0 (0)         0.001[c](#tf0050){ref-type="table-fn"}
   Moderate (score 16--23)           20 (54.1)     0 (0)         0.231[c](#tf0050){ref-type="table-fn"}
   Severe (score 24--31)             9 (24.3)      0 (0)         1.000[c](#tf0050){ref-type="table-fn"}
   Extreme (score 32--40)            1 (2.7)       0 (0)         1.000[c](#tf0050){ref-type="table-fn"}

HR = high risk; HV = healthy controls; SD = standard deviation; n = number; PANSS = Positive and Negative Syndrome Scale, BDI-II = Beck Depression Inventory, Version II, BAI = Beck Anxiety Inventory, YMRS = Young Mania Rating Scale, YBOCS = Yale-Brown Obsessive Compulsive Scale.

^†^Number of missing observations in brackets.

Independent *t*-test.

Chi-square test.

Fisher\'s exact test.

###### 

Functioning and quality of life comparison between HR individuals and healthy volunteers.

  Functioning and quality of life measures^†^    HR (n = 60)   HV (n = 45)   p-Value
  ---------------------------------------------- ------------- ------------- -------------------------------------------
  GAF, mean (SD) (3)                                                         
   Symptoms                                      45.4 (8.9)    86.6 (3.8)    \< 0.001[a](#tf0065){ref-type="table-fn"}
   Disability                                    48.6 (9.4)    86.7 (3.6)    \< 0.001[a](#tf0065){ref-type="table-fn"}
  Occupational status, n (%) (7)^‡^                                          0.061[b](#tf0070){ref-type="table-fn"}
   Unemployed                                    20 (37.7)     8 (17.8)      0.029[b](#tf0070){ref-type="table-fn"}
   Employed                                      16 (30.2)     22 (48.9)     0.058[b](#tf0070){ref-type="table-fn"}
   Students                                      17 (32.1)     15 (33.3)     0.895[b](#tf0070){ref-type="table-fn"}
  MANSA, mean (SD) (11)                          3.8 (1.0)     5.6 (0.6)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Life as a whole today                         3.4 (1.5)     5.6 (1.0)     0.001[c](#tf0075){ref-type="table-fn"}
   Health                                        3.5 (1.4)     5.4 (1.1)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Present mental health                         3.0 (1.4)     6.2 (0.8)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Job (if working)                              4.1 (1.8)     5.4 (1.4)     0.011[c](#tf0075){ref-type="table-fn"}
   Not working (if not working)                  3.7 (1.7)     4.0 (1.9)     0.532[c](#tf0075){ref-type="table-fn"}
   Financial situation                           3.5 (1.5)     4.6 (1.5)     0.001[c](#tf0075){ref-type="table-fn"}
   Leisure activities                            3.9 (1.9)     5.6 (1.3)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Number of friends                             4.2 (1.8)     5.8 (1.0)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Relationships with friends                    4.5 (1.7)     5.7 (0.9)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Personal safety                               4.0 (1.6)     5.8 (0.9)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Accommodation                                 4.6 (1.7)     6.0 (1.2)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   People one live with (if living with other)   4.7 (1.4)     6.1 (0.9)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Living alone (if living alone)                4.0 (--)      --            --
   Relationship with family                      4.0 (1.4)     5.6 (1.0)     \< 0.001[c](#tf0075){ref-type="table-fn"}
   Life overall                                  3.0 (1.4)     5.8 (0.9)     \< 0.001[c](#tf0075){ref-type="table-fn"}

HR = high risk; HV = healthy controls; SD = standard deviation; n = number; GAF = Global Assessment of Functioning; MANSA = Manchester Short Assessment of Quality of Life.

^†^Number of missing observations in brackets.

^‡^Employment status is broadly categorized into 3 groups. 'Unemployed' includes subjects who do not have a job, either they are looking for work, not looking for work (e.g., housewife), or not being able to work due to medical reasons. 'Employed' refers to people who have full/part-time employment, or employed but currently unable to work. 'Students' refer to full/part-time students.

Mann--Whitney *U* test.

Chi-square test.

Independent *t*-test.
